Germany · Delayed Price · Currency is EUR Newron Pharmaceuticals Statistics
Total Valuation
FRA:NP5 has a market cap or net worth of EUR 313.73 million. The enterprise value is 323.20 million.
| Market Cap | 313.73M |
| Enterprise Value | 323.20M |
Important Dates
The next estimated earnings date is Thursday, December 18, 2025.
| Earnings Date | Dec 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 19.96M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +16.86% |
| Shares Change (QoQ) | -11.63% |
| Owned by Insiders (%) | 4.81% |
| Owned by Institutions (%) | 6.02% |
| Float | 19.00M |
Valuation Ratios
The trailing PE ratio is 12.39.
| PE Ratio | 12.39 |
| Forward PE | n/a |
| PS Ratio | 5.24 |
| PB Ratio | 198.31 |
| P/TBV Ratio | 198.44 |
| P/FCF Ratio | 12.79 |
| P/OCF Ratio | 12.77 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.04, with an EV/FCF ratio of 13.18.
| EV / Earnings | 12.76 |
| EV / Sales | 5.34 |
| EV / EBITDA | 9.04 |
| EV / EBIT | 9.08 |
| EV / FCF | 13.18 |
Financial Position
The company has a current ratio of 1.51, with a Debt / Equity ratio of 33.23.
| Current Ratio | 1.51 |
| Quick Ratio | 1.40 |
| Debt / Equity | 33.23 |
| Debt / EBITDA | 1.49 |
| Debt / FCF | 2.14 |
| Interest Coverage | 8.00 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 50.97% |
| Return on Invested Capital (ROIC) | 60.97% |
| Return on Capital Employed (ROCE) | 165.16% |
| Revenue Per Employee | 2.72M |
| Profits Per Employee | 1.15M |
| Employee Count | 22 |
| Asset Turnover | 1.39 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, FRA:NP5 has paid 5.55 million in taxes.
| Income Tax | 5.55M |
| Effective Tax Rate | 17.99% |
Stock Price Statistics
The stock price has increased by +56.30% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +56.30% |
| 50-Day Moving Average | 11.35 |
| 200-Day Moving Average | 9.09 |
| Relative Strength Index (RSI) | 58.52 |
| Average Volume (20 Days) | 999 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:NP5 had revenue of EUR 59.88 million and earned 25.33 million in profits. Earnings per share was 1.19.
| Revenue | 59.88M |
| Gross Profit | 59.88M |
| Operating Income | 35.20M |
| Pretax Income | 30.88M |
| Net Income | 25.33M |
| EBITDA | 35.21M |
| EBIT | 35.20M |
| Earnings Per Share (EPS) | 1.19 |
Balance Sheet
The company has 43.20 million in cash and 52.57 million in debt, giving a net cash position of -9.37 million.
| Cash & Cash Equivalents | 43.20M |
| Total Debt | 52.57M |
| Net Cash | -9.37M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.58M |
| Book Value Per Share | 0.08 |
| Working Capital | 20.39M |
Cash Flow
In the last 12 months, operating cash flow was 24.57 million and capital expenditures -37,000, giving a free cash flow of 24.53 million.
| Operating Cash Flow | 24.57M |
| Capital Expenditures | -37,000 |
| Free Cash Flow | 24.53M |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of 58.78% and 42.30%.
| Gross Margin | 100.00% |
| Operating Margin | 58.78% |
| Pretax Margin | 51.57% |
| Profit Margin | 42.30% |
| EBITDA Margin | 58.81% |
| EBIT Margin | 58.78% |
| FCF Margin | 40.96% |
Dividends & Yields
FRA:NP5 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.86% |
| Shareholder Yield | -16.86% |
| Earnings Yield | 8.07% |
| FCF Yield | 7.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:NP5 has an Altman Z-Score of 4.83 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.83 |
| Piotroski F-Score | 5 |